Thinking Digital: When qPCR Doesn’t Make the Cut

Bio-Rad experts Eddy van Collenburg and Jörg Bantin will discuss where your research can greatly benefit from using ddPCR rather than qPCR, as well as how to ensure a seamless transition to ddPCR.

Event Details:Thinking Digital: When qPCR Doesn’t Make the CutDate(s):

Expert Discussion

Thursday, November 4, 2021
4:00 PM Central European Time (11:00 AM ET)

Register Now

Quantitative PCR (qPCR) is one of the most widely used tools in genomics. It is so powerful and user-friendly that researchers tend to over rely on it. Every technique has its limitations, and qPCR is no exception. There are situations where a more refined PCR technique such as Droplet Digital PCR (ddPCR) could yield superior results. In this webinar brought to you by Bio-Rad, Jörg Bantin and Eddy van Collenburg will discuss when ddPCR should be used instead of qPCR and how to ease the transition.

Topics to be covered

Register Now

Meet the Speaker:

Jörg Bantin, PhD
Regional Specialist, ddPCR
Bio-Rad, Germany

Eddy van Collenburg
Market Development Specialist, ddPCR
Bio-Rad, Netherlands

Interested in reading more?

800x560-nov-4

The Scientist ARCHIVES

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!

Join for free today

Already a member? Login Here

Related Topics

Share

Related Research Resources

Conceptual 3D illustration of mycoplasma colonies

Taking Control of Cellular Contamination with PCR Testing

Article

Digital microscopy image of cells in culture

Electronic Records in Cell Culture Management

Article

Conceptual image of gene sequencing showing multicolored bands in a spiral arrangement on a black background.

Rare Disease Research Gets a Boost from Automated NGS Solutions

Article

A photo of a sample storage box sitting on metal racks in a liquid nitrogen-cooled freezer.

Best Practices for Freezing Cell Cultures

Article

Image of small blue creatures called Nergals. Some have hearts above their heads, which signify friendship. There is one Nergal who is sneezing and losing health, which is denoted by minus one signs floating around it.

June 2025, Issue 1

Nergal Networks: Where Friendship Meets Infection

A citizen science game explores how social choices and networks can influence how an illness moves through a population.

View this Issue

Research Resources

Podcasts

Webinars

Videos

Infographics

eBooks

An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

By fine-tuning polishing conditions, scientists attain high titers of infectious lentiviral particles during purification.

Unraveling Complex Biology with Advanced Multiomics Technology

Unraveling Complex Biology with Five-Dimensional Multiomics

Learn how a next-generation platform accelerates biological research by enabling high-throughput, spatially resolved multiomics profiling.

Resurrecting Plant Defense Mechanisms to Avoid Crop Pathogens

Resurrecting Plant Defense Mechanisms to Avoid Crop Pathogens

In this webinar, Imogen Binnian will share how AI and gene synthesis technology can accelerate the discovery and validation of novel disease traits.

The Scientist Placeholder Image

Seeing and Sorting with Confidence

Real-time imaging enhances fluorescence activated cell sorting (FACS) to help scientists overcome the cost and burden of validation.

Products

Product News

The Scientist Placeholder Image

Waters Enhances Alliance iS HPLC System Software, Setting a New Standard for End-to-End Traceability and Data Integrity

Industry-first smart HPLC system to provide authenticated user access verification on onboard touchscreen for superior security.

The Scientist Placeholder Image

Agilent Unveils the Next Generation in LC-Mass Detection: The InfinityLab Pro iQ Series

Setting new standards for intelligent mass detection, sensitivity, and sustainability.

Agilent Announces the Enhanced 8850 Gas Chromatograph

Compact, Powerful, and now Mass Spec-Connected for Superior Analytical Performance

Pioneering Cancer Plasticity Atlas will help Predict Response to Cancer Therapies

The Wellcome Sanger Institute, Helmholtz Munich, and Parse Biosciences have announced a landmark international collaboration to create a Cancer Plasticity Atlas.